Intra-Cellular Therapies
ITCI
#1825
Rank
ยฃ7.22 B
Marketcap
ยฃ68.17
Share price
0.28%
Change (1 day)
43.79%
Change (1 year)

Earnings for Intra-Cellular Therapies (ITCI)

Earnings in 2024 (TTM): -ยฃ66.04 Million

According to Intra-Cellular Therapies's latest financial reports the company's current earnings are ยฃ0.61 Billion. In 2023 the company made an earning of -ยฃ0.12 Billion, an increase over its 2022 earnings that were of -ยฃ0.21 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Intra-Cellular Therapies from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ66.04 Million-40.3%
2023 -ยฃ0.12 Billion-45.74%
2022 -ยฃ0.21 Billion-9.81%
2021 -ยฃ0.23 Billion25.17%
2020 -ยฃ0.19 Billion53.66%
2019 -ยฃ0.12 Billion-4.77%
2018 -ยฃ0.13 Billion56.96%
2017 -ยฃ78.63 Million-14.33%
2016 -ยฃ91.78 Million10.09%
2015 -ยฃ83.37 Million241.45%
2014 -ยฃ24.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ6.5 Million-90.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ37.09 Million-45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.14 Billion 104.06%๐Ÿ‡บ๐Ÿ‡ธ USA